JP2025510700A5 - - Google Patents

Info

Publication number
JP2025510700A5
JP2025510700A5 JP2024556005A JP2024556005A JP2025510700A5 JP 2025510700 A5 JP2025510700 A5 JP 2025510700A5 JP 2024556005 A JP2024556005 A JP 2024556005A JP 2024556005 A JP2024556005 A JP 2024556005A JP 2025510700 A5 JP2025510700 A5 JP 2025510700A5
Authority
JP
Japan
Prior art keywords
antibody
antibody conjugate
linker
hetero
range
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024556005A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025510700A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2023/057561 external-priority patent/WO2023180485A1/en
Publication of JP2025510700A publication Critical patent/JP2025510700A/ja
Publication of JP2025510700A5 publication Critical patent/JP2025510700A5/ja
Pending legal-status Critical Current

Links

JP2024556005A 2022-03-23 2023-03-23 Trop-2を発現する腫瘍を標的化するための抗体コンジュゲート Pending JP2025510700A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22163943 2022-03-23
EP22163943.8 2022-03-23
PCT/EP2023/057561 WO2023180485A1 (en) 2022-03-23 2023-03-23 Antibody-conjugates for targeting of tumours expressing trop-2

Publications (2)

Publication Number Publication Date
JP2025510700A JP2025510700A (ja) 2025-04-15
JP2025510700A5 true JP2025510700A5 (cg-RX-API-DMAC10.html) 2026-03-31

Family

ID=81308125

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024556005A Pending JP2025510700A (ja) 2022-03-23 2023-03-23 Trop-2を発現する腫瘍を標的化するための抗体コンジュゲート

Country Status (10)

Country Link
US (1) US20250090679A1 (cg-RX-API-DMAC10.html)
EP (1) EP4496594A1 (cg-RX-API-DMAC10.html)
JP (1) JP2025510700A (cg-RX-API-DMAC10.html)
KR (1) KR20250024743A (cg-RX-API-DMAC10.html)
CN (1) CN119212731A (cg-RX-API-DMAC10.html)
AU (1) AU2023241225A1 (cg-RX-API-DMAC10.html)
CA (1) CA3253220A1 (cg-RX-API-DMAC10.html)
IL (1) IL315207A (cg-RX-API-DMAC10.html)
MX (1) MX2024011520A (cg-RX-API-DMAC10.html)
WO (1) WO2023180485A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3876998A1 (en) 2018-11-05 2021-09-15 Synaffix B.V. Antibody-conjugates for targeting of tumours expressing trop-2
IL315366A (en) 2022-03-23 2024-11-01 Synaffix Bv Antibody pairs for targeting PTK7-expressing tumors

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939255A (en) 1987-06-24 1990-07-03 Daiichi Pharmaceutical Co., Ltd. Hexa-cyclic camptothecin derivatives
CA2235269C (en) 1995-10-19 2006-09-19 Bristol-Myers Squibb Company Monoclonal antibody br110 and uses thereof
US9745380B2 (en) 2002-03-01 2017-08-29 Immunomedics, Inc. RS7 antibodies
CA2478047C (en) 2002-03-01 2014-01-21 Immunomedics, Inc. Rs7 antibodies
US20070249014A1 (en) 2006-02-10 2007-10-25 Invitrogen Corporation Labeling and detection of post translationally modified proteins
US7420040B2 (en) 2006-02-24 2008-09-02 Arius Research Inc. Cytotoxicity mediation of cells evidencing surface expression of TROP-2
US20080131428A1 (en) 2006-02-24 2008-06-05 Arius Research, Inc. Cytotoxicity mediation of cells evidencing surface expression of TROP-2
WO2009102820A2 (en) 2008-02-11 2009-08-20 Government Of The U.S A., As Represented By The Secretary, Department Of Health And Human Services Modified sugar substrates and methods of use
JP2012516887A (ja) 2009-02-05 2012-07-26 オンコックス・エッセ・エッレ・エッレ 抗trop−2モノクローナル抗体ならびに腫瘍の治療および診断におけるその使用
WO2011155579A1 (ja) 2010-06-10 2011-12-15 北海道公立大学法人札幌医科大学 抗Trop-2抗体
SG11201401699WA (en) 2011-11-11 2014-09-26 Rinat Neuroscience Corp Antibodies specific for trop-2 and their uses
US9427464B2 (en) 2011-11-22 2016-08-30 Chiome Bioscience Inc. Anti-human TROP-2 antibody having an antitumor activity in vivo
HRP20180268T4 (hr) 2012-10-23 2026-03-27 Synaffix B.V. Modificirano antitijelo, konjugat antitijela i postupak za njihovu pripremu
WO2015012904A2 (en) 2012-12-13 2015-01-29 Immunomedics, Inc. Antibody-sn-38 immunoconjugates with a cl2a linker
SG10201902571VA (en) 2013-12-25 2019-04-29 Daiichi Sankyo Co Ltd Anti-trop2 antibody-drug conjugate
EP3177633B1 (en) 2014-08-04 2022-07-20 SynAffix B.V. Process for the modification of a glycoprotein using a beta-(1,4)-n-acetylgalactosaminyltransferase or a mutant thereof
EP3733209A1 (en) 2014-10-03 2020-11-04 Synaffix B.V. Sulfamide linker, conjugates thereof, and methods of preparation
CN107810273B (zh) 2015-04-23 2022-09-27 西纳福克斯股份有限公司 用为或衍生自β-(1,4)-N-乙酰半乳糖胺转移酶的糖基转移酶修饰糖蛋白的方法
CA3026651A1 (en) 2016-06-09 2017-12-14 Blinkbio, Inc. Silanol based therapeutic payloads
TWI920652B (zh) 2018-06-07 2026-04-01 美商思進公司 喜樹鹼結合物
EP3876998A1 (en) * 2018-11-05 2021-09-15 Synaffix B.V. Antibody-conjugates for targeting of tumours expressing trop-2
KR20240104214A (ko) 2019-03-29 2024-07-04 메디뮨 리미티드 화합물 및 이의 접합체
RS64961B1 (sr) 2019-04-26 2024-01-31 Immunogen Inc Derivati kamptotecina
KR20230021018A (ko) 2020-06-05 2023-02-13 재단법인 생물기술개발중심 항-메조텔린 항체를 함유하는 항체-약물 컨쥬게이트 및 이의 용도
NL2026947B1 (en) 2020-11-20 2022-07-01 Synaffix Bv Tyrosine-based antibody conjugates
CN113816969B (zh) 2021-04-30 2024-01-16 联宁(苏州)生物制药有限公司 依喜替康类化合物、其抗体药物偶联物及其应用
US12533419B2 (en) 2021-07-19 2026-01-27 Mabplex International Co., Ltd. Antibody drug conjugate loaded with binary toxins and its application

Similar Documents

Publication Publication Date Title
Chittaboina et al. One-pot synthesis of triazole-linked glycoconjugates
US20090181402A1 (en) Compositions and methods for coupling a plurality of compounds to a scaffold
US10030066B2 (en) Immune receptor modifier conjugate and preparation method and use thereof, coupling precursor for preparing same, and compound for synthesizing coupling precursor
JP2020000252A5 (cg-RX-API-DMAC10.html)
JP2020114818A5 (cg-RX-API-DMAC10.html)
JP5825507B2 (ja) 分岐型ヘテロポリエチレングリコール
FI89172B (fi) Nya oligosackarider och deras anvaendning foer framstaellning av immunogener
AU2013237497B2 (en) Carbohydrate-glycolipid conjugate vaccines
EP2121030A2 (en) Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites
US20200261560A1 (en) Precision glycoconjugates as therapeutic tools
US20120322955A1 (en) Polyoxyethylene derivative having plural hydroxyl groups at terminal end thereof
US9365598B2 (en) Phosphine derivatives of fluorescent compounds
JP2025510623A5 (cg-RX-API-DMAC10.html)
JP2025510678A5 (cg-RX-API-DMAC10.html)
WO2026016269A1 (zh) 一种用于主动靶向表皮生长因子受体检测的近红外荧光探针及其制备方法与应用
JP5612467B2 (ja) Fmocをベースとした加水分解性リンカーの調製方法
JP2015157946A (ja) 分岐型ヘテロポリエチレングリコールおよび中間体
JP2908558B2 (ja) 炭水化物のアクリル及びメタクリルコポリマー並びに該ポリマーの製造方法
US20240000964A1 (en) Compound or salt thereof, and antibody obtained by using the same
WO2023180485A1 (en) Antibody-conjugates for targeting of tumours expressing trop-2
JP2012502011A5 (cg-RX-API-DMAC10.html)
JP2001510853A (ja) ポリエーテルホスフェートの製造方法
US20080220005A1 (en) Comb Polymers
CN1742057A (zh) 用于荧光诊断的亲水性硫醇反应性花青染料及其与生物分子的缀合物
KR20230157983A (ko) 당사슬 및 당사슬을 포함하는 의약품의 제조 방법